Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Tarantino

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Pediatric Blood & Cancer|September 9, 2020
Romiplostim treatment for children with immune thrombocytopenia: Results of an integrated database of five clinical trialsMichael D Tarantino, Jenny Despotovic, John Roy, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 6, 2025
Best practices to reduce microbial contamination during media-fill testing process in hospital pharmacies: a scoping review of literatureS Bruno, M C Nurchis, F Pattavina, et al.
Transfusion|October 11, 2011
RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME)Jenny M Despotovic, Michele P Lambert, Jay H Herman, et al.
Journal of Blood Medicine|April 15, 2021
Severe, Refractory Immune Thrombocytopenia Occurring After SARS-CoV-2 VaccineJackie M Helms, Kristin T Ansteatt, Jonathan C Roberts, et al.
Journal of Blood Medicine|March 5, 2021
Efficacy of rFVIIIFc versus Emicizumab for the Treatment of Patients with Hemophilia A without Inhibitors: Matching-Adjusted Indirect Comparison of A-LONG and HAVEN TrialsRobert Klamroth, Piotr Wojciechowski, Samuel Aballéa, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 25, 2017
Radionuclide synovectomy/synoviorthesis (RS) in patients with bleeding disorders: A review of patient and procedure demographics and functional outcomes in the ATHNdatasetC McGuinn, D Cheng, D Aschman, et al.
Haematologica|March 9, 2019
Long-term treatment with romiplostim and treatment-free platelet responses in children with chronic immune thrombocytopeniaMichael D Tarantino, James B Bussel, Victor S Blanchette, et al.
British Journal of Haematology|January 13, 2021
Fostamatinib is an effective second-line therapy in patients with immune thrombocytopeniaRalph Boccia, Nichola Cooper, Waleed Ghanima, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 16, 2023
Real-world safety and effectiveness of recombinant porcine sequence factor VIII in acquired haemophilia A: A non-interventional, post-authorization safety studyMichael D Tarantino, Brandon Hardesty, Ara Metjian, et al.
Blood|June 8, 2007
A closer look at intravascular hemolysis (IVH) following intravenous anti-D for immune thrombocytopenic purpura (ITP)Michael D Tarantino, James B Bussel, Douglas B Cines, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Pediatric Blood & Cancer|September 9, 2020
Romiplostim treatment for children with immune thrombocytopenia: Results of an integrated database of five clinical trialsMichael D Tarantino, Jenny Despotovic, John Roy, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 6, 2025
Best practices to reduce microbial contamination during media-fill testing process in hospital pharmacies: a scoping review of literatureS Bruno, M C Nurchis, F Pattavina, et al.
Transfusion|October 11, 2011
RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME)Jenny M Despotovic, Michele P Lambert, Jay H Herman, et al.
Journal of Blood Medicine|April 15, 2021
Severe, Refractory Immune Thrombocytopenia Occurring After SARS-CoV-2 VaccineJackie M Helms, Kristin T Ansteatt, Jonathan C Roberts, et al.
Journal of Blood Medicine|March 5, 2021
Efficacy of rFVIIIFc versus Emicizumab for the Treatment of Patients with Hemophilia A without Inhibitors: Matching-Adjusted Indirect Comparison of A-LONG and HAVEN TrialsRobert Klamroth, Piotr Wojciechowski, Samuel Aballéa, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 25, 2017
Radionuclide synovectomy/synoviorthesis (RS) in patients with bleeding disorders: A review of patient and procedure demographics and functional outcomes in the ATHNdatasetC McGuinn, D Cheng, D Aschman, et al.
Haematologica|March 9, 2019
Long-term treatment with romiplostim and treatment-free platelet responses in children with chronic immune thrombocytopeniaMichael D Tarantino, James B Bussel, Victor S Blanchette, et al.
British Journal of Haematology|January 13, 2021
Fostamatinib is an effective second-line therapy in patients with immune thrombocytopeniaRalph Boccia, Nichola Cooper, Waleed Ghanima, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 16, 2023
Real-world safety and effectiveness of recombinant porcine sequence factor VIII in acquired haemophilia A: A non-interventional, post-authorization safety studyMichael D Tarantino, Brandon Hardesty, Ara Metjian, et al.
Blood|June 8, 2007
A closer look at intravascular hemolysis (IVH) following intravenous anti-D for immune thrombocytopenic purpura (ITP)Michael D Tarantino, James B Bussel, Douglas B Cines, et al.
Pageof 11